Pharmanutra Logo

Pharmanutra

Develops and distributes nutritional supplements and medical devices based on research.

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA

Description

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-11-25 07:57
PR - PHARMANUTRA - THREE NEW PATENTS RELEASED
English 178.5 KB
2021-11-25 07:54
CS - PHARMANUTRA SPA - RILASCIATI TRE NUOVI ATTESTATI DI BREVETTO
Italian 181.8 KB
2021-11-16 07:54
PR - PHARMANUTRA SPA Distribution agreement Argentina
English 178.9 KB
2021-11-16 07:53
CS - PHARMANUTRA SPA Accordo distribuzione Argentina
Italian 182.5 KB
2021-11-12 16:21
CS - PHARMANUTRA SPA Interim Financial Report as of 30 September 2021
English 169.5 KB
2021-11-12 16:11
CS - PHARMANUTRA SPA - Deposito del Resoconto Intermedio di Gestione al 30 sett…
Italian 171.3 KB
2021-11-12 16:07
PHARMANUTRA SPA - INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2021
English 1.9 MB
2021-11-12 16:06
PHARMANUTRA SPA - RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2021
Italian 1.9 MB
2021-11-08 17:20
PR - PHARMANUTRA - Board of directors approves interim management report as at …
English 251.4 KB
2021-11-08 17:16
CS - PHARMANUTRA - il CDA approva il resoconto intermedio di gestione al 30 09 …
Italian 279.4 KB
2021-10-25 07:56
PR - PHARMANUTRA Ultraberb patent Alesco
English 180.4 KB
2021-10-25 07:54
CS - PHARMANUTRA brevetto Ultraberb Alesco
Italian 181.1 KB
2021-10-21 07:45
PR - PHARMANUTRA Cetilar patent in India
English 178.6 KB
2021-10-21 07:43
CS - PHARMANUTRA Brevetto cetilar India 21102021
Italian 182.2 KB
2021-10-13 08:37
CS - PHARMANUTRA accordi commerciali internazionali
Italian 183.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmanutra

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750
CHOONG ANG VACCINE LABORATORY Logo
Develops and manufactures vaccines, pharmaceuticals, and feed additives for animals.
South Korea
072020
CHOSA Oncology AB Logo
Develops diagnostics and therapeutics for platinum-based chemotherapy.
Sweden
CHOSA
CHUGAI PHARMACEUTICAL CO., LTD. Logo
A research-driven pharmaceutical company developing innovative medical products.
Japan
4519
CHUKYOIYAKUHIN CO.,LTD. Logo
Offers health products and pharmaceuticals via a direct-to-home placement service.
Japan
4558
Cidara Therapeutics, Inc. Logo
Develops targeted immunotherapies and anti-infectives for serious diseases.
United States of America
CDTX
Cinclus Pharma Holding AB Logo
Clinical-stage pharma company developing a PCAB for gastric acid-related diseases.
Sweden
CINPHA
Cingulate Inc. Logo
A clinical-stage biopharma firm developing treatments for ADHD and anxiety.
United States of America
CING
CITIUS ONCOLOGY, INC. Logo
Biopharmaceutical company developing and commercializing targeted oncology therapies.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
A late-stage biopharmaceutical company developing and commercializing critical care products.
United States of America
CTXR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.